Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194298 · ClinicalTrials.gov registry record
FDG-PET Imaging in Complicated Diabetic Foot
A clinical trial of Diabetic Foot Disease, sponsored by University of Pennsylvania.
- Active
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT00194298: Active study of Diabetic Foot Disease, sponsored by University of Pennsylvania.
NCT00194298 is a study of Diabetic Foot Disease that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194298, a study of Diabetic Foot Disease, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of the proposed research study is to determine the potential utilization of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with complicated diabetic foot, especially in the diagnosis or exclusion of osteomyelitis in this setting. We intend to validate and establish the necessary criteria for making such a diagnosis and determine the accuracy of the technique through comparison with other existing modalities, including MRI, and patient outcome. We expect that at the completion of the proposed research, the role of these powerful imaging modalities will be clearly defined in the management of patients with this challenging and serious complication.
Primary Outcome
Standardized Uptake Value
Conditions Studied
Interventions
- PROCEDURE FDG-PET Imaging
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2002-10 |
| Est. Completion | 2027-02 |
What the registry record for NCT00194298 still lists
NCT00194298 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Diabetic Foot Disease appearing as the primary indexed condition, and to 1 intervention - of which FDG-PET Imaging is the first listed.
NCT00194298 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00194298 about?
NCT00194298 is a clinical study titled "FDG-PET Imaging in Complicated Diabetic Foot". The main objective of the proposed research study is to determine the potential utilization of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with complicated diabetic foot, especially in the diagnosis or exclusion of osteomyelitis in this setting. We intend to vali...
What is the current status of trial NCT00194298?
This trial is currently active not recruiting. The enrollment target is 240 participants. The study started on 2002-10. Estimated completion is 2027-02.
What conditions does trial NCT00194298 study?
This clinical trial studies the following conditions: Diabetic Foot Disease.
What interventions are being tested in trial NCT00194298?
The interventions under investigation include: FDG-PET Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00194298?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194298 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia